Arcus Biosciences, Inc. — Director's Dealing 2018

Oct 23, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2018-10-19

Reporting Person: Hege Kristen (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$13.55	2028-04-09	Common Stock (8000)		Direct

Footnotes

F1: The option is exercisable in 48 equal monthly installments after March 26, 2018 provided the reporting person remains in continuous service on each vesting date.